|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R33657-100UG
|
| NSJ Bioreagents |
|
100 ug |
|
|
|
|
ELA-E0013r
|
| Lifescience Market |
|
96 Tests |
|
|
|
|
ELA-E0014r
|
| Lifescience Market |
|
96 Tests |
|
|
|
|
ELA-E0646r
|
| Lifescience Market |
|
96 Tests |
|
|
|
|
ELA-E0799r
|
| Lifescience Market |
|
96 Tests |
|
|
|
|
|
|
|
|
|
20R-1737
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 13 antibody
|
|
|
|
|
20R-1824
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 14 antibody
|
|
|
|
|
20R-1825
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 10 antibody
|
|
|
|
|
20R-1840
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 3 antibody
|
|
|
|
|
|
20R-1841
|
| Fitzgerald |
|
100 ug |
|
Description: Goat polyclonal BMP 3 antibody
|
|
|
|
|
20R-1842
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 4 antibody
|
|
|
|
|
20R-1843
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 5 antibody
|
|
|
|
|
20R-1845
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 6 antibody
|
|
|
|
|
20R-1847
|
| Fitzgerald |
|
100 ug |
|
Description: Rabbit polyclonal BMP 7 antibody
|
|
|
|
|
|
20R-1848
|
| Fitzgerald |
|
100 ug |
|
Description: Goat polyclonal BMP 7 antibody
|
|
|
|
|
ABD8507
|
| Lifescience Market |
|
100 ug |
|
|
|
|
HY-P7006
|
| MedChemExpress |
|
10ug |
|
|
|
|
HY-P7007
|
| MedChemExpress |
|
50ug |
|
|
|
|
HY-P7008
|
| MedChemExpress |
|
50ug |
|
|
|
|
HY-P7332
|
| MedChemExpress |
|
10ug |
|
|
|
|
|
|
|
|
PR15013CF
|
| Neuromics |
|
10 ug |
|
|
|
|
PR15015CF
|
| Neuromics |
|
10 ug |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A03443-1
|
| BosterBio |
|
100ul |
|
Description: Rabbit Polyclonal Antibody for BMP-9 Antibody (GDF2) detection.tested for IHC in Human, Mouse.
|
|
|
|
|
A04449-1
|
| BosterBio |
|
100ul |
|
Description: Rabbit Polyclonal Antibody for BMP-3A Antibody (BMP3) detection.tested for IHC, WB in Human, Mouse, Rat.
|
|
|
|
|
A06924
|
| BosterBio |
|
100ul |
|
Description: Rabbit Polyclonal Antibody for BMP-6 Antibody (BMP6) detection. Tested with WB in Human, Mouse, Rat.
|
|
|
|
|
A06968-1
|
| BosterBio |
|
100ul |
|
Description: Rabbit Polyclonal Antibody for BMP-10 Antibody (BMP10) detection. Tested with WB in Human, Mouse, Rat.
|
|
|
|
|
A11711
|
| BosterBio |
|
100ul |
|
Description: Rabbit Polyclonal Antibody for BMP-8A Antibody (BMP8A) detection.tested for IHC, WB in Human, Mouse, Rat.
|
|
|
|
|
40-106-0002mg
|
| ProSci |
|
0.002 mg |
|
Description: BMPs (Bone Morphogenetic Proteins) belong to the TGF-beta superfamily of structurally related signaling proteins. BMP-2 is a potent osteoinductive cytokine, capable of inducing bone and cartilage formation in association with osteoconductive carriers such as collagen and synthetic hydroxyapatite. In addition to its osteogenic activity, BMP-2 plays an important role in cardiac morphogenesis and is expressed in a variety of tissues including lung, spleen, brain, liver, prostate ovary and small intestine. The functional form of BMP-2 is a 26 kDa protein composed of two identical 114 amino acid polypeptide chains linked by a single disulfide bond. Each BMP-2 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 23 amino acid signal sequence for secretion, and a 259 amino acid propeptide. After dimerization of this precursor, the covalent bonds between the propeptide (which is also a disulfide-linked homodimer) and the mature BMP-2 ligand are cleaved by a furin-type protease. Recombinant human BMP-2 is a 26.0 kDa homodimeric protein consisting of two 115 amino acid polypeptide chains.
|
|
|
|
|
|
40-106-001mg
|
| ProSci |
|
0.01 mg |
|
Description: BMPs (Bone Morphogenetic Proteins) belong to the TGF-beta superfamily of structurally related signaling proteins. BMP-2 is a potent osteoinductive cytokine, capable of inducing bone and cartilage formation in association with osteoconductive carriers such as collagen and synthetic hydroxyapatite. In addition to its osteogenic activity, BMP-2 plays an important role in cardiac morphogenesis and is expressed in a variety of tissues including lung, spleen, brain, liver, prostate ovary and small intestine. The functional form of BMP-2 is a 26 kDa protein composed of two identical 114 amino acid polypeptide chains linked by a single disulfide bond. Each BMP-2 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 23 amino acid signal sequence for secretion, and a 259 amino acid propeptide. After dimerization of this precursor, the covalent bonds between the propeptide (which is also a disulfide-linked homodimer) and the mature BMP-2 ligand are cleaved by a furin-type protease. Recombinant human BMP-2 is a 26.0 kDa homodimeric protein consisting of two 115 amino acid polypeptide chains.
|
|
|
|
|
40-203-0001mg
|
| ProSci |
|
0.001 mg |
|
Description: Bone morphogenetic proteins (BMPs) constitute a subfamily within the TGF-β superfamily of structurally related signaling proteins. Members of this superfamily are widely distributed throughout the body and are involved in diverse physiological processes during both pre- and postnatal life. Like BMP-7, BMP-4 is involved in the development and maintenance of bone and cartilage. Reduced expression of BMP-4 is associated with a number of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. Recombinant human BMP-4, expressed in HeLa cells, is a 31-36 kDa homodimeric glycoprotein.
|
|
|
|
|
|
40-203-0005mg
|
| ProSci |
|
0.005 mg |
|
Description: Bone morphogenetic proteins (BMPs) constitute a subfamily within the TGF-β superfamily of structurally related signaling proteins. Members of this superfamily are widely distributed throughout the body and are involved in diverse physiological processes during both pre- and postnatal life. Like BMP-7, BMP-4 is involved in the development and maintenance of bone and cartilage. Reduced expression of BMP-4 is associated with a number of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. Recombinant human BMP-4, expressed in HeLa cells, is a 31-36 kDa homodimeric glycoprotein.
|
|
|
|
|
40-204-0002mg
|
| ProSci |
|
0.002 mg |
|
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling and maintenance of a variety of other tissues and organs. Increasing evidence indicates that BMP-Smad signaling has a tumor suppressing activity and that BMPs can inhibit tumor growth. BMP-6 is abnormally expressed in breast cancer cell lines; however, its function in promoting breast cancer development is unknown. Recombinant human BMP-6 is a 26.2 kDa homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 397 to 513 of the full-length BMP-6 precursor.
|
|
|
|
|
|
40-204-001mg
|
| ProSci |
|
0.01 mg |
|
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling and maintenance of a variety of other tissues and organs. Increasing evidence indicates that BMP-Smad signaling has a tumor suppressing activity and that BMPs can inhibit tumor growth. BMP-6 is abnormally expressed in breast cancer cell lines; however, its function in promoting breast cancer development is unknown. Recombinant human BMP-6 is a 26.2 kDa homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 397 to 513 of the full-length BMP-6 precursor.
|
|
|
|
|
32204-05111
|
| AssayPro |
|
150 ug |
|
|
|
|
32558-05111
|
| AssayPro |
|
150 ug |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40-615-0002mg
|
| ProSci |
|
0.002 mg |
|
Description: Bone morphogenetic proteins (BMPs) constitute a subfamily within the TGF-β superfamily of structurally related signaling proteins. Members of this superfamily are widely distributed throughout the body and are involved in diverse physiological processes during both pre- and postnatal life. Like BMP-7, BMP-4 is involved in the development and maintenance of bone and cartilage. Reduced expression of BMP-4 is associated with a number of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. PeproTech’s E.coli derived murine BMP-4 is a fully active homodimeric protein consisting of two 106 amino acid subunits which correspond to amino acids 303-408 of the full length BMP-4 precursor.
|
|
|
|
|
|
40-615-001mg
|
| ProSci |
|
0.01 mg |
|
Description: Bone morphogenetic proteins (BMPs) constitute a subfamily within the TGF-β superfamily of structurally related signaling proteins. Members of this superfamily are widely distributed throughout the body and are involved in diverse physiological processes during both pre- and postnatal life. Like BMP-7, BMP-4 is involved in the development and maintenance of bone and cartilage. Reduced expression of BMP-4 is associated with a number of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. PeproTech’s E.coli derived murine BMP-4 is a fully active homodimeric protein consisting of two 106 amino acid subunits which correspond to amino acids 303-408 of the full length BMP-4 precursor.
|
|
|
|
|
|
40-640
|
| ProSci |
|
2 ug |
|
Description: BMPs (Bone Morphogenetic Proteins) belong to the TGF-β superfamily of structurally related signaling proteins. BMP-2 is a potent osteoinductive cytokine, capable of inducing bone and cartilage formation in association with an osteoconductive carrier such as collagen and synthetic hydroxyapatite. In addition to its osteogenic activity, BMP-2 appears to play an important role in cardiac morphogenesis, and is expressed in a variety of other tissues, including lung, liver, spleen, prostate, ovary, and small intestine. The functional form of BMP-2 is a 26 kDa protein composed of two identical 114 amino acid polypeptide chains (monomers) linked by a single disulfide bond. Each BMP-2 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 23 amino acid signal sequence for secretion, and a 259 amino acid propeptide. After dimerization of this precursor, the covalent bonds between the propeptide (which is also a disulfide-linked homodimer) and the mature BMP-2 ligand are cleaved by a furin-type protease. Recombinant Human/Murine/Rat BMP-2 derived from CHO cells is a homodimeric glycoprotein that consists of two 114 amino acid polypeptide chains linked by a single disulfide bond. Due to glycosylation, CHO cell-derived Human/Murine/Rat BMP-2 migrates at an apparent molecular weight of approximately 28-29 kDa by SDS-PAGE analysis under non-reducing conditions.
|
|
|
|
|
40-641
|
| ProSci |
|
2 ug |
|
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth, and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling, and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of an appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant Human BMP-7 is a 28.8 kDa homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 315 to 431 of the full-length BMP-7 precursor.
|
|
|
|
|
|
40-642
|
| ProSci |
|
2 ug |
|
Description: TGF-β family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth, and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling, and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of an appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects. A bone-graft substitute, called OP-1TM implant, made of recombinant human BMP-7 associated with bovine bone-derived collagen, has recently been approved by the FDA as a device for treating critical-size bone fractures. The potential use of BMP-7 in dental reconstructive surgeries is currently under investigation. Recombinant Human BMP-7 is a homodimeric glycoprotein consisting of two 117 amino acid subunits, which correspond to amino acid residues 315 to 431 of the full-length BMP-7 precursor. Recombinant Human BMP-7 has a calculated molecular weight of 26.4 kDa; however, due to glycosylation, the BMP-7 homodimer migrates at an apparent molecular weight of approximately 25-35 kDa by SDS-PAGE analysis under non-reducing conditions.
|
|
|
|
|
40-648
|
| ProSci |
|
2 ug |
|
Description: Bone morphogenetic proteins (BMPs) constitute a subfamily within the TGF-β superfamily of structurally related signaling proteins. Members of this superfamily are widely distributed throughout the body and are involved in diverse physiological processes during both pre- and postnatal life. BMP-10 plays a crucial role in the development of the embryonic heart by acting to stimulate and maintain cardiomyocyte proliferation. It can signal through various receptor complexes usually containing BMPR-1A, BMPR-1B, ALK1, ALK3, or ALK6. The interaction of BMP-10 with its specific receptors can induce signaling initiated by the phosphorylation of SMAD transcription factors, including SMAD1, SMAD5, or SMAD8, but can also induce SMAD independent processes. BMP-10 is structurally related to BMP-9, and both can inhibit endothelial cell proliferation and migration. Recombinant Human BMP-10 is a 24.4 kDa homodimeric disulfide-linked protein consisting of two 108 amino acid subunits, which correspond to amino acid residues 317 to 424 of the full-length BMP-10 precursor.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
